Annexin Pharmaceuticals AB Strategic Asset Allocation Index
Annexin Pharmaceuticals AB strategic asset allocation index. Annexin Pharmaceuticals AB (ANNX) has a Strategic Asset Allocation Index of 4.5% as of December 2025. Strategic assets (PP&E of Skr1.12 Million plus long-term investments of Skr-) total Skr1.12 Million, measured against net assets of Skr24.93 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Annexin Pharmaceuticals AB net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Annexin Pharmaceuticals AB (2017–2025)
Strategic asset allocation index of Annexin Pharmaceuticals AB from 2017 to 2025. This chart shows how Annexin Pharmaceuticals AB's Strategic Asset Allocation Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 4.5%, representing strategic assets of Skr1.12 Million against net assets of Skr24.93 Million SEK. Check Annexin Pharmaceuticals AB (ANNX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annexin Pharmaceuticals AB Strategic Asset Allocation Index by Year (2017–2025)
Annexin Pharmaceuticals AB strategic asset allocation index by year from 2017 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Annexin Pharmaceuticals AB from 2017 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ANNX market cap.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 4.5% | Skr1.12 Million | Skr1.12 Million | Skr- | Skr24.93 Million | ▼ -3.4 pp |
| 2024 | 7.8% | Skr1.08 Million | Skr1.08 Million | Skr- | Skr13.71 Million | ▲ +1.6 pp |
| 2023 | 6.2% | Skr1.17 Million | Skr1.17 Million | Skr- | Skr18.81 Million | ▲ +2.0 pp |
| 2022 | 4.2% | Skr1.26 Million | Skr1.26 Million | Skr- | Skr30.15 Million | ▲ +1.3 pp |
| 2021 | 2.9% | Skr1.35 Million | Skr1.35 Million | Skr- | Skr46.73 Million | ▼ -4.1 pp |
| 2020 | 7.0% | Skr1.44 Million | Skr1.44 Million | Skr- | Skr20.64 Million | ▼ -6.3 pp |
| 2019 | 13.3% | Skr1.52 Million | Skr1.52 Million | Skr- | Skr11.49 Million | ▲ +9.2 pp |
| 2018 | 4.1% | Skr1.61 Million | Skr1.61 Million | Skr- | Skr39.85 Million | ▼ -2.9 pp |
| 2017 | 7.0% | Skr1.70 Million | Skr1.70 Million | Skr- | Skr24.44 Million | — |